Empowering Natural Tissue Regeneration
Empowering Natural Tissue Regeneration

Osteopore (ASX: OSX) announces a strategic sub-distribution partnership with Kelyniam through its U.S. sales distribution partner, Bioplate Inc. to further penetrate the USD1.1 billion cranial implant market.

Contact a Representative

Are you a Healthcare Professional?

The content of the Healthcare Professional pages is intended for a medical specialist audience only.
By using this site or downloading materials from the site, you agree to abide by the terms and conditions set forth in our Privacy Policy and Legal Notice.

No, I am not a Healthcare professional. Please take me to the Patient Care content, or the Homepage.